Amiloxate

Amiloxate is a sunscreening agent. It is approved for use in the European Union and is undergoing regulatory evaluation in the United States.[1][2]

Amiloxate
Names
IUPAC name
3-Methylbutyl (2E)-3-(4-methoxyphenyl)acrylate
Other names
Isopentyl 4-methoxycinnamate; Isoamyl p-methoxycinnamate
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard 100.068.798
UNII
Properties
C15H20O3
Molar mass 248.322 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

See also

References

  1. Brian Palmer. "Burned by Bureaucracy: Why is the FDA stalling on newer and better sunscreens?". Slate.com.
  2. Britt Erickson (May 12, 2014). "Sunscreen Delays". Chemical & Engineering News. 92 (19): 27.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.